UPDATE : Monday, September 7, 2020
상단여백
Drugmakers boost production capacity amid Covid-19 by Kim Chan-hyuk 2020-08-28 14:57
Genexine's cytokine drug effective on severe Covid-19 patients by Shim Hyun-tai 2020-08-27 18:05
Drugmakers to sue government for limiting choline alfoscerate benefit by Kim Yun-mi 2020-08-27 14:26
Stocks of 3 Covid-19 vaccine developers spike by Kim Chan-hyuk 2020-08-27 14:07
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease by Shim Hyun-tai 2020-08-26 17:47
라인
HK inno.N, T&R Biofab to develop skin therapy using 3D tech by Shim Hyun-tai 2020-08-26 16:19
Novartis fails trial on skin cancer drug candidate spartalizumab by Kim Yun-mi 2020-08-26 11:11
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status by Shim Hyun-tai 2020-08-25 17:07
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate by Shim Hyun-tai 2020-08-25 16:57
Huons' eye drop wins Saudi’s regulatory nod by Shim Hyun-tai 2020-08-25 14:50
라인
HK inno.N publishes P3 trial results of drug on gastric ulcers by Shim Hyun-tai 2020-08-24 18:02
Intron Bio secures new drug substance for bacterial pneumonia by Shim Hyun-tai 2020-08-24 18:01
GC Pharma collects more plasma to speed up work on Covid-19 treatment by Kim Chan-hyuk 2020-08-24 17:15
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax by Shim Hyun-tai 2020-08-24 16:12
Genexine begins global P3 trial of anemia drug by Shim Hyun-tai 2020-08-24 16:12
라인
Drug sales reps refrain from visiting doctors amid Covid-19 resurge by Kim Yun-mi 2020-08-21 16:00
Hanmi terminates global P2 trial for poziotinib by Lee Han-soo 2020-08-21 15:56
Daewoong to co-develop esophagitis drug for treating Covid-19 by Shim Hyun-tai 2020-08-20 18:41
Yuhan licenses out gastrointestinal treatment to US partner by Lee Han-soo 2020-08-20 16:58
Regulator OKs P2 trial of Covid-19 plasma therapy by Lee Han-soo 2020-08-20 14:55
여백
여백
여백
Back to Top